Camille Powe, MD, discusses how discontinuing GLP-1 receptor agonists before or during pregnancy may increase gestational weight gain and metabolic risks.
Camille Powe, MD
Advertisement
Camille Powe, MD, is an endocrinologist at Mass General Brigham.
Articles by Camille Powe, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Top women's health headlines you missed in November 2025
2
GLP-1 discontinuation tied to increased weight gain and pregnancy complications
3
Endometriosis found more prevalent than adenomyosis
4
How invisible symptoms and provider bias delay endometriosis diagnosis
5
